ENTITY

Dyadic International (DYAI US)

3
Analysis
Health CareUnited States
Dyadic International, Inc. is a global biotechnology company. The Company focuses on improving and applying the proprietary C1 expression system to help drug developers and manufacturers bring biologic drugs to market. Dyadic International focuses on drugs that will improve access and cost to patients as well as save lives.
more
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x